Citi raised the firm’s price target on Teladoc (TDOC) to $7 from $6 and keeps a Neutral rating on the shares post the Q’ report. The firm cites BetterHelp’s better than expected results for the target boost.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc Hold Rating Reaffirmed as 2026 Outlook Tightens and $6 DCF-Based Price Target Remains Unchanged
- Unchanged Risk Disclosures at Teladoc Raise Questions About Emerging Threats and Investor Exposure
- Teladoc Earnings Call: Insurance Momentum Amid Headwinds
- Teladoc price target lowered to $5.50 from $6 at Stifel
- Closing Bell Movers: Meta falls 6%, Alphabet jumps 6% after earnings